XT
BNGO icon

XTX Topco’s Bionano Genomics BNGO Stock Holding History

XTX Topco’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,621
Closed -$45.4K – 2442
2024
Q4 		$45.4K Buy
+2,621
New +$44.8K ﹤0.01% 1912
2024
Q2 		– Sell
-1,614
Closed -$108K – 1894
2024
Q1 		$108K Buy
+1,614
New +$120K 0.01% 1349
2023
Q3 		– Sell
-136
Closed -$49.7K – 1579
2023
Q2 		$49.7K Buy
+136
New +$61.4K 0.01% 1236
2023
Q1 		– Sell
-146
Closed -$128K – 1287
2022
Q4 		$128K Buy
+146
New +$184K 0.03% 954
2021
Q3 		– Sell
-17
Closed -$76K – 706
2021
Q2 		$76K Buy
+17
New +$67.1K 0.03% 689

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return

XTX Topco's BNGO Position: Q1 2025 in Review

XTX Topco sold out of Bionano Genomics (BNGO) in Q1 2025, closing a stake of 2,621 shares — an estimated $45.4K sold.

XTX Topco first reported a position in BNGO in Q2 2021 and held it in 5 quarters. The position peaked at $128K in Q4 2022. 30 funds tracked by Wall St. Rank hold BNGO as of Q1 2025.

  • XTX Topco reported no remaining Bionano Genomics position as of Q1 2025 after selling out during the quarter.
  • XTX Topco sold 2,621 Bionano Genomics shares in Q1 2025, an estimated $45.4K.
  • XTX Topco first reported a position in Bionano Genomics in Q2 2021 and held it in 5 quarters.
  • XTX Topco's Bionano Genomics position peaked at $128K in Q4 2022.
  • 30 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2025.

Based on XTX Topco's 13F filing for Q1 2025, filed 8 May 2025.